Daily FNArena News - Australia

Deusche Bank looks at emerging comapniues exposed to US growth while JP Morgan forecasts changes to index constiuents.

Citi suggests China will slow its slowing while Merrill Lynch sees value in Australian banks.

A Sonic boom has hit supposedly defensive medical companies, with Primary feeling the shock waves. But on the flipside, predators have pounced on embattled Sigma and Healthscope.

Given a weaker Aussie, Credit Suisse has reviewed the basic materials sector to determine winners and losers.

Housing starts are up and investors are returning to the local residential market while REITs with US exposure are again riding the fortunes of the exchange rate.

Morgan Stanley looks at the RSPT impact on BHP and Rio, Merrill Lynch downgrades Rio, and Macquarie comments on Fortescue.

Of all the negative influences currently impacting on the Australian stock market, none is greater than “Oh God I’ve seen this movie before”.

David Jones delivered a soft March quarter sales result and some brokers are now questioning where earnings growth will come from in coming periods.

Credit Suisse today initiated coverage on Premier Investments with an Outperform rating, while Citi has upgraded to a Buy.

Westpac’s Australian consumer confidence index has tipped over, Germany’s confidence has plunged, and the US consumer is none too enthusiastic either.